Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 73, Issue 2
EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) is sensitive to show efficacy of rituximab treatment in a randomised controlled trial
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Letter
EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) is sensitive to show efficacy of rituximab treatment in a randomised controlled trial
Online download statistics by month:
Online download statistics by month: August 2013 to April 2023
Abstract
Full
Pdf
Aug 2013
390
56
86
Sep 2013
47
24
30
Oct 2013
73
35
32
Nov 2013
67
29
31
Dec 2013
121
33
43
Jan 2014
237
36
87
Feb 2014
72
34
44
Mar 2014
83
36
41
Apr 2014
95
20
28
May 2014
49
12
14
Jun 2014
43
15
21
Jul 2014
45
11
15
Aug 2014
34
6
10
Sep 2014
31
10
15
Oct 2014
35
14
19
Nov 2014
33
12
9
Dec 2014
15
7
8
Jan 2015
30
8
10
Feb 2015
24
12
19
Mar 2015
16
8
11
Apr 2015
13
23
13
May 2015
21
11
12
Jun 2015
17
6
14
Jul 2015
18
12
11
Aug 2015
18
13
8
Sep 2015
28
16
18
Oct 2015
20
0
3
Nov 2015
30
13
19
Dec 2015
17
7
10
Jan 2016
25
10
9
Feb 2016
17
10
5
Mar 2016
19
9
9
Apr 2016
17
9
10
May 2016
25
10
15
Jun 2016
26
0
7
Jul 2016
19
3
3
Aug 2016
18
6
9
Sep 2016
20
2
6
Oct 2016
28
6
8
Nov 2016
26
5
5
Dec 2016
22
5
2
Jan 2017
23
8
11
Feb 2017
44
14
11
Mar 2017
19
7
9
Apr 2017
25
5
8
May 2017
23
1
7
Jun 2017
62
9
20
Jul 2017
70
6
17
Aug 2017
134
7
10
Sep 2017
98
6
8
Oct 2017
139
4
9
Nov 2017
104
5
10
Dec 2017
96
8
9
Jan 2018
148
3
7
Feb 2018
97
12
13
Mar 2018
54
5
1
Apr 2018
58
11
8
May 2018
76
7
1
Jun 2018
79
2
0
Jul 2018
55
4
4
Aug 2018
70
4
2
Sep 2018
45
9
3
Oct 2018
82
8
0
Nov 2018
130
18
5
Dec 2018
101
13
1
Jan 2019
101
14
3
Feb 2019
79
14
3
Mar 2019
86
14
4
Apr 2019
43
6
3
May 2019
35
9
4
Jun 2019
53
6
3
Jul 2019
35
7
1
Aug 2019
56
5
1
Sep 2019
45
2
2
Oct 2019
62
10
4
Nov 2019
60
4
1
Dec 2019
18
4
4
Jan 2020
44
9
4
Feb 2020
19
7
2
Mar 2020
36
8
2
Apr 2020
35
1
0
May 2020
134
6
3
Jun 2020
242
7
2
Jul 2020
43
2
0
Aug 2020
23
5
1
Sep 2020
330
3
2
Oct 2020
338
3
0
Nov 2020
113
5
3
Dec 2020
27
7
4
Jan 2021
37
2
1
Feb 2021
22
2
1
Mar 2021
42
4
3
Apr 2021
14
1
0
May 2021
14
3
3
Jun 2021
3
3
0
Jul 2021
3
3
2
Aug 2021
1
0
0
Sep 2021
5
5
0
Oct 2021
25
9
2
Nov 2021
78
4
2
Dec 2021
40
6
3
Jan 2022
22
2
2
Feb 2022
46
1
2
Mar 2022
37
3
3
Apr 2022
39
0
0
May 2022
56
2
0
Jun 2022
47
5
2
Jul 2022
43
3
1
Aug 2022
66
6
1
Sep 2022
77
9
2
Oct 2022
78
5
2
Nov 2022
42
3
1
Dec 2022
45
7
1
Jan 2023
12
2
0
Feb 2023
97
2
1
Mar 2023
60
3
0
Apr 2023
33
0
0
Total
6957
1023
1034
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF